NeoGenomics, Inc.NEONASDAQ
LOADING
|||
NEO Revenue Growth (YoY Quarterly)•+11.90%
SAPRO
Growth Metrics
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +10.44% | +10.57% | +7.55% | +10.23% | +11.90% |
| Gross Profit Growth | +20.17% | +14.31% | +11.88% | +6.57% | +7.43% |
| EBITDA Growth | +0.00% | -22.54% | +0.00% | -3753.31% | -659.73% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.01% | +0.58% | +1.00% | +1.22% | +0.76% |
| Weighted Average Shares Diluted Growth | +1.01% | +0.58% | +1.00% | +1.22% | +0.76% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -44.89% | +0.00% | +46.34% | -3.92% |
| Free Cash Flow Growth | +0.00% | -116.77% | +0.00% | +1620.76% | +0.00% |
| Receivables Growth | +14.16% | +14.68% | +6.40% | +4.81% | +2.88% |
| Inventory Growth | +1.68% | +10.73% | +46.52% | +47.20% | +16.37% |
| Asset Growth | -2.21% | -2.57% | -2.37% | -15.17% | -16.23% |
| Book Value per Share Growth | -5.10% | -4.71% | -4.76% | -7.88% | -8.39% |
| Debt Growth | +0.09% | -1.04% | -0.56% | -32.11% | -32.32% |
| R&D Expense Growth | +45.39% | +11.81% | +33.61% | +14.42% | +13.14% |
| SG&A Expenses Growth | +10.48% | +10.47% | +5.66% | +12.73% | +4.92% |
1 / 4